2,850
Participants
Start Date
March 1, 2022
Primary Completion Date
December 31, 2024
Study Completion Date
March 30, 2025
GFAP and UCH-L1
2x5mL blood samples will be used to determine the performance of the automated VIDAS TBI platform in assessing serum concentrations of GFAP and UCH-L1 to rule out the need for a CT-scan after mTBI.
RECRUITING
Hospital Universitario 12 de Octubre, Madrid
RECRUITING
CHU Clermont-Ferrand, Clermont-Ferrand
RECRUITING
CHU Grenoble-Alpes, Grenoble
RECRUITING
Hôpital Edouard HERRIOT, Lyon
RECRUITING
Hôpital Lyon Sud HCL, Lyon
RECRUITING
Klinikum rechts der Isar, Munich
RECRUITING
Hospital Universitari Vall d'Hebron, Barcelona
Collaborators (2)
Technical University of Munich
OTHER
University Hospital, Grenoble
OTHER
University Hospital, Clermont-Ferrand
OTHER
Hospital Vall d'Hebron
OTHER
BioMérieux
INDUSTRY
EIT Health
OTHER
Hospital Universitario 12 de Octubre
OTHER